全文获取类型
收费全文 | 6556篇 |
免费 | 359篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 104篇 |
儿科学 | 100篇 |
妇产科学 | 130篇 |
基础医学 | 980篇 |
口腔科学 | 56篇 |
临床医学 | 483篇 |
内科学 | 1252篇 |
皮肤病学 | 279篇 |
神经病学 | 534篇 |
特种医学 | 563篇 |
外科学 | 980篇 |
综合类 | 37篇 |
一般理论 | 1篇 |
预防医学 | 277篇 |
眼科学 | 177篇 |
药学 | 341篇 |
中国医学 | 4篇 |
肿瘤学 | 651篇 |
出版年
2023年 | 37篇 |
2022年 | 56篇 |
2021年 | 119篇 |
2020年 | 98篇 |
2019年 | 125篇 |
2018年 | 140篇 |
2017年 | 132篇 |
2016年 | 127篇 |
2015年 | 175篇 |
2014年 | 191篇 |
2013年 | 280篇 |
2012年 | 431篇 |
2011年 | 452篇 |
2010年 | 270篇 |
2009年 | 255篇 |
2008年 | 436篇 |
2007年 | 428篇 |
2006年 | 419篇 |
2005年 | 403篇 |
2004年 | 400篇 |
2003年 | 395篇 |
2002年 | 290篇 |
2001年 | 74篇 |
2000年 | 53篇 |
1999年 | 89篇 |
1998年 | 85篇 |
1997年 | 77篇 |
1996年 | 57篇 |
1995年 | 48篇 |
1994年 | 49篇 |
1993年 | 29篇 |
1992年 | 51篇 |
1991年 | 33篇 |
1990年 | 39篇 |
1989年 | 31篇 |
1988年 | 36篇 |
1987年 | 32篇 |
1986年 | 33篇 |
1985年 | 35篇 |
1984年 | 29篇 |
1983年 | 31篇 |
1982年 | 29篇 |
1981年 | 19篇 |
1980年 | 20篇 |
1979年 | 20篇 |
1978年 | 25篇 |
1977年 | 19篇 |
1976年 | 12篇 |
1973年 | 18篇 |
1972年 | 16篇 |
排序方式: 共有6949条查询结果,搜索用时 0 毫秒
81.
Evaluation of an ICD‐10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients 下载免费PDF全文
82.
Jean Bousquet Claus Bachert Jonathan Bernstein G Walter Canonica Warner Carr Ronald Dahl 《Expert opinion on pharmacotherapy》2015,16(6):913-928
Introduction: Effective pharmacologic treatment exists for most patients suffering from allergic rhinitis (AR). However, both in clinical trials and in real-life studies, many patients are dissatisfied with treatment. Physicians often use multiple therapies, in an attempt to improve symptom control, often with limited evidence of success. Novel treatment options are needed and must consider unmet medical needs.Areas covered: This article reviews the clinical data for a new AR treatment. MP29-02 (Dymista®, Meda, Solna, Sweden) contains azelastine hydrochloride (AZE) and fluticasone propionate (FP), in a novel formulation and delivered in an improved device as a single nasal spray. It has shown superior efficacy in AR patients than either commercially available AZE or FP monotherapy for both nasal and ocular symptom relief, regardless of disease severity. MP29-02 also provided more effective and rapid symptom relief than either AZE or FP monotherapy delivered in the MP29-02 formulation and device. However, the effect was less than that observed versus commercial comparators, suggesting the impact of formulation and device on clinical efficacy.Expert opinion: MP29-02 simplifies AR management, surpassing the efficacy of gold standard treatment, intranasal corticosteroids (INS), for the first time. It is indicated for the treatment of moderate-to-severe seasonal allergic rhinitis and perennial allergic rhinitis when monotherapy with either intranasal antihistamine or INS is NOT considered sufficient. Most patients present with moderate/severe disease, with evidence of current or previous treatment insufficiency. MP29-02 should be the treatment of choice for these patients. 相似文献
83.
84.
Maes Marina L. Saseen Joseph J. Wright Garth Claus Liza W. 《Clinical rheumatology》2021,40(3):1017-1026
Clinical Rheumatology - Determine the real-world incidence of acute gout prophylaxis (AGP) prescribing when a xanthine oxidase inhibitor (XOI) is initiated and describe characteristics of AGP... 相似文献
85.
86.
87.
László B Tankó Lusine Movsesyan Ulrik Mouritzen Claus Christiansen Ole L Svendsen 《Metabolism: clinical and experimental》2002,51(1):69-74
Studies indicate that deficient skeletal muscle mass or sarcopenia is a major cause of disability and morbidity among the elderly. In part, due to the lack of generally applicable normal values, there is still insufficient epidemiologic data available on the frequency and severity of sarcopenia in health and under various disease-related conditions. The objectives of the present study were to (1) characterize the age- and menopause-related variations in appendicular lean tissue mass (LTM(A)), (2) provide young-normal means and estimate the age-specific prevalence of sarcopenia among healthy women. A total of 754 healthy women were included in the study of cross-sectional design. LTM(A) was estimated by dual-energy x-ray absorptiometry (DEXA). Physical characteristics and menopausal status were also registered. LTM(A) as well as height showed significant negative correlation with age with Pearson's r values of -0.43 and -0.06, respectively (P <.05). Trend of finding lower mean values with advancing age remained even when LTM(A) was adjusted for height(2) (ht(2)). Menopause did not seem to have any influence on LTM(A). Young-normal means were obtained from 216 premenopausal women aged 18 to 39 years. Prevalence rates of sarcopenia in healthy women were determined with reference to a cut-off line corresponding to LTM(A) or LTM(A)/ht(2) less than young-normal mean 2 SD and were found to be 40.2% and 12.3%, respectively, among the healthy elderly (>70 years of age). Results of the present study provide further evidence that sarcopenia exists even among otherwise healthy women with increasing age-specific prevalence. Further studies are needed (1) to estimate the prevalence of sarcopenia under various health and disease-related conditions with reference to the hereby given cut-off values and (2) to find therapeutic strategies with beneficial effects in conserving skeletal muscle mass. 相似文献
88.
Andreas E. Kulozik John Lyons Elisabeth Kohne Claus R. Bartram Enno Kleihauer 《British journal of haematology》1988,70(4):455-458
The standard method for the prenatal diagnosis of the haemoglobinopathies is by restriction enzyme mapping of chorionic villus DNA using Southern blotting and radioactively labelled gene probes. An improvement of the procedure which involves the selective amplification of DNA fragments by the polymerase chain reaction allows one to visualize restriction fragments directly without the use of radioactivity and within 2 d after obtaining the sample. We report here the prenatal diagnosis of two pregnancies at risk for homozygous beta thalassaemia and homozygous sickle cell disease using this novel approach. 相似文献
89.
BACKGROUND: Congestive heart failure (CHF) has previously been shown to be associated with insulin resistance and hyperinsulinemia. A beneficial effect of the non-selective beta-blocker carvedilol has been demonstrated in patients with CHF. However, whether the drug affects the insulin sensitivity (S(i)) is unknown. AIMS: To investigate whether treatment with carvedilol alters the S(i) in patients with CHF during a prospective, double-blinded, placebo-controlled study. METHODS AND RESULTS: The patients were randomized to receive either carvedilol (n=29) or matched placebo (n=17). Insulin and glucose responses were measured during a 0.3 g/kg intravenous glucose tolerance test, and S(i) was calculated according to Bergman's Minimal Model. Baseline S(i) values correlated significantly with body mass index (r=-0.42, P=0.002), plasma urate (r=-0.42, P=0.002), plasma HDL-cholesterol (r=0.39, P=0.003), maximal oxygen uptake (r=0.35, P=0.009), plasma triglycerides (r=-0.34, P=0.01) and weight (r=-0.29, P=0.03). During the study the insulin sensitivity was unchanged in the carvedilol group compared with placebo (2.63+/-1.45 to 2.38+/-1.64 vs. 2.81+/-2.36 to 2.48+/-1.84x10(-4) min(-1)/mUl(-1), P=0.83). CONCLUSION: Additional treatment with carvedilol is neutral with regard to influence the insulin sensitivity in patients with mild to moderate CHF. 相似文献
90.
Genetic polymorphisms in the tumour necrosis factor locus in childhood acute lymphoblastic leukaemia 总被引:1,自引:0,他引:1
Takeuchi S Takeuchi N Tsukasaki K Bartram CR Zimmermann M Schrappe M Taguchi H Koeffler HP 《British journal of haematology》2002,119(4):985-987
Genetic polymorphisms in the tumour necrosis factor (TNF) locus influence the outcome of non-Hodgkin's lymphoma (NHL). We investigated whether these polymorphisms might contribute to the clinical course of childhood acute lymphoblastic leukaemia (ALL). Genomic DNA from 214 childhood ALL patients was analysed. Patients with a high-risk haplotype were older than patients with low-risk haplotype (P = 0.024). No statistically significant associations were found between TNF haplotype and sex, WBC counts, central nervous system involvement, immunophenotype, response to chemotherapy, and event-free survival. These data suggest that genetic polymorphisms in the TNF locus have a limited effect on the outcome of childhood ALL. 相似文献